
Sign up to save your podcasts
Or
Plus: NovoNordisk downgrades its guidance amid competition from copycat versions of its weight-loss and diabetes drugs. And U.S. electric vehicle sales drop despite growth in the broader car market. Kate Bullivant hosts.
Sign up for WSJ’s free What’s News newsletter.
Learn more about your ad choices. Visit megaphone.fm/adchoices
4.2
623623 ratings
Plus: NovoNordisk downgrades its guidance amid competition from copycat versions of its weight-loss and diabetes drugs. And U.S. electric vehicle sales drop despite growth in the broader car market. Kate Bullivant hosts.
Sign up for WSJ’s free What’s News newsletter.
Learn more about your ad choices. Visit megaphone.fm/adchoices
1,627 Listeners
4,319 Listeners
1,741 Listeners
401 Listeners
423 Listeners
2,791 Listeners
1,456 Listeners
1,011 Listeners
1,267 Listeners
5,917 Listeners
1,538 Listeners
192 Listeners
1,319 Listeners
573 Listeners
151 Listeners
50 Listeners
72 Listeners
134 Listeners